Preparation method of isavuconazonium sulfate intermediate

A technology of isavuconazolium and intermediates, applied in the field of drug synthesis, can solve the problems of high risk of lithium tetrahydrogen, unfavorable industrial production, and inconvenient post-processing, so as to save energy consumption, be beneficial to environmental protection, and reduce side effects. less responsive effect

Inactive Publication Date: 2021-12-31
KAIFENG MINGREN PHARMA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0015] In the above existing preparation methods, lithium aluminum hydride is used for catalytic hydrogenation, the reaction conditions are high, the r

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of isavuconazonium sulfate intermediate
  • Preparation method of isavuconazonium sulfate intermediate
  • Preparation method of isavuconazonium sulfate intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] The preparation method of isavuconazolium sulfate intermediate of the present invention, the detailed steps of this preparation method are as follows:

[0051] a. Synthesis of 1-chloroethyl methylcarbamate:

[0052] Add 1500 mL of absolute ethanol and 204 g (3 mol) of sodium ethoxide into the reaction flask for stirring and dissolving. After fully dissolving, add 67.5 g (1 mol) of methylamine hydrochloride and stir for 30 min at room temperature. After the reaction, cool the resulting reaction solution to 0 ℃;

[0053] Then 143g (1mol) 1-chloroethyl chloroformate is dissolved in 1500mL dehydrated alcohol, and the gained 1-chloroethyl chloroformate ethanol solution after dissolving is slowly dripped in the above-mentioned cooling gained reaction solution, and the dropping time is 30min; After the dropwise addition, react at 0°C for 2h, filter after the reaction, and the obtained filtrate is methylcarbamate-1-chloroethyl ethanol solution;

[0054] b, (3-hydroxymethyl-py...

Embodiment 2

[0062] The preparation method of isavuconazolium sulfate intermediate of the present invention, the detailed steps of this preparation method are as follows:

[0063] a. Synthesis of 1-chloroethyl methylcarbamate:

[0064] Add 1360mL of absolute ethanol and 136.1g (2mol) of sodium ethoxide into the reaction flask and stir to dissolve. After fully dissolving, add 87.8g (1.3mol) of methylamine hydrochloride and stir at room temperature for 60min. After the reaction, cool the resulting reaction solution to -20°C;

[0065] Then 143g (1mol) 1-chloroethyl chloroformate is dissolved in 2145mL dehydrated alcohol, and the gained 1-chloroethyl chloroformate ethanol solution after dissolving is slowly dripped in the reaction solution obtained by the above-mentioned cooling, and the dropping time is 60min; After the dropwise addition, react at -10°C for 3h, filter after the reaction, and the obtained filtrate is methylcarbamate-1-chloroethyl ethanol solution;

[0066] b, (3-hydroxymethy...

Embodiment 3

[0074] The preparation method of isavuconazolium sulfate intermediate of the present invention, the detailed steps of this preparation method are as follows:

[0075] a. Synthesis of 1-chloroethyl methylcarbamate:

[0076] Add 1910mL of absolute ethanol and 272.2g (4mol) of sodium ethoxide into the reaction flask and stir to dissolve. After fully dissolving, add 81.0g (1.2mol) of methylamine hydrochloride and stir at room temperature for 45min. After the reaction, cool down the resulting reaction solution to -10°C;

[0077] Then 143g (1mol) 1-chloroethyl chloroformate is dissolved in 1700mL dehydrated alcohol, and the gained 1-chloroethyl chloroformate ethanol solution after dissolving is slowly dripped in the reaction solution obtained by the above-mentioned cooling, and the dropping time is 45min; After the dropwise addition, react at -5°C for 3h, filter after the reaction, and the obtained filtrate is methylcarbamate-1-chloroethyl ethanol solution;

[0078] b, (3-hydroxym...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method of an isavuconazonium sulfate intermediate. The preparation method comprises the following steps: firstly, reacting absolute ethyl alcohol, sodium ethoxide and methylamine hydrochloride, cooling an obtained reaction solution, adding an ethanol solution of 1-chloroethyl methylcarbamate for continuous reaction, and conducting filtering to obtain an ethanol solution of methyl carbamic acid-1-chloroethyl ester; cooling the obtained solution, adding an ethanol solution of 2-chloro-3-pyridinemethanol for stirring reaction, filtering a reactant, removing ethanol, adding dichloromethane for dissolving, conducting washing after dissolving, and taking an organic phase, namely a dichloromethane solution of 1-chloro-ethyl (3-hydroxymethyl-pyridin-2-yl)-methylcarbamate; and firstly adding BOC-sarcosine into the obtained solution, then adding carbodiimide and 4-dimethylaminopyridine in batches for a reaction, and performing treatment after the reaction, so as to obtain the isavuconazole onium sulfate intermediate. The isavuconazonium sulfate is prepared by using the technical scheme of the invention, the side reaction of the process is less, and the purity of the obtained product is high.

Description

1. Technical field: [0001] The invention relates to the technical field of drug synthesis, in particular to a preparation method of an isavuconazolium sulfate intermediate. 2. Background technology: [0002] Isavuconazole is an antifungal drug for the treatment of invasive aspergillosis and mucormycosis jointly developed by Baselia Pharmaceutical Co., Ltd. and Astellas Pharmaceuticals, and has been granted orphan status by the FDA and the European Medicines Agency drug qualifications. On March 6, 2015, the U.S. FDA gave priority to the listing of Astellas Isavuconazole Sulfate under the trade name Cresemba, and on October 15, 2015, the European Commission granted the marketing authorization of Basilea Pharmaceuticals Isavuconazole. [0003] The chemical name of isavuconazolium sulfate is N-methylglycine [2-[[[1-[1-[(2R,3R)-3-[4-(4-cyanophenyl)-2-thiazole Base]-2-(2,5-difluorophenyl)-2-hydroxybutyl]-4H-1,2,4-triazolium-4-yl]ethoxy]carbonyl]methylamino]-3 -pyridyl] methyl s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D213/75
CPCC07D213/75
Inventor 李运铎张煜晨张永超李沁沁常欢张银霞王翠霞季萍张亚慧
Owner KAIFENG MINGREN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap